Sintx Technologies (SINT) Net Income towards Common Stockholders (2013 - 2026)
Sintx Technologies (SINT) recorded quarterly Net Income towards Common Stockholders of -$2.8 million in Q1 2026, down 27.36% quarter-over-quarter from -$2.2 million in Q4 2025, and down 22.87% on a YoY basis from -$3.7 million in Q1 2025.
Sintx Technologies (SINT) Net Income towards Common Stockholders (2013 - 2026) Analysis & Trends
Sintx Technologies' Net Income towards Common Stockholders history runs 14 years deep, the most recent figure standing at -$2.8 million for Q1 2026.
- In Q1 2026, Net Income towards Common Stockholders fell 22.87% year-over-year to -$2.8 million; the TTM figure through Mar 2026 stood at -$17.6 million (down 85.18% YoY), while the FY2025 annual figure was -$17.1 million, down 50.98% from the prior year.
- Net Income towards Common Stockholders was -$2.8 million for Q1 2026 at Sintx Technologies, down from -$2.2 million in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of $2.4 million in Q4 2023 to a low of -$11.0 million in Q4 2022.
- Historically, Net Income towards Common Stockholders has averaged -$3.4 million across 5 years, with a median of -$2.8 million in 2022.
- The sharpest annual moves came in 2022 and 2023: Net Income towards Common Stockholders plunged 288.94% in 2022, then jumped 122.08% in 2023.
- A 5-year view of Net Income towards Common Stockholders shows it stood at -$11.0 million in 2022, then surged by 122.08% to $2.4 million in 2023, then sank by 36.46% to $1.5 million in 2024, then slumped by 243.46% to -$2.2 million in 2025, then decreased by 27.36% to -$2.8 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at -$2.8 million (Q1 2026), -$2.2 million (Q4 2025), and -$10.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 411.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 187,319.30 |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 199.50 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | Sintx Technologies | 8.79 Mn | 6.90 Mn | 144,000.00 | -2.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.82 Mn |
| Dec 31, 2025 | -2.22 Mn |
| Sep 30, 2025 | -10.26 Mn |
| Jun 30, 2025 | -2.32 Mn |
| Mar 31, 2025 | -2.30 Mn |
| Dec 31, 2024 | 1.54 Mn |
| Sep 30, 2024 | -6.24 Mn |
| Jun 30, 2024 | -2.52 Mn |
| Mar 31, 2024 | -3.73 Mn |
| Dec 31, 2023 | 2.43 Mn |
| Sep 30, 2023 | -3.19 Mn |
| Jun 30, 2023 | -2.48 Mn |
| Mar 31, 2023 | -4.44 Mn |
| Dec 31, 2022 | -11.01 Mn |
| Sep 30, 2022 | -2.78 Mn |
| Jun 30, 2022 | -2.62 Mn |
| Mar 31, 2022 | -2.85 Mn |
| Dec 31, 2021 | -2.83 Mn |
| Sep 30, 2021 | -2.82 Mn |
| Jun 30, 2021 | -2.20 Mn |